華潤置地(01109.HK)投得東莞商住地 擬建成大型高端商業綜合體
華潤置地(01109.HK)公布,於8月11日成功獲取東莞市南城街道東莞國際商務區2021WR020地塊,總佔地面積約14.4萬平方米,計容總建築面積約83萬平方米,將建設建築面積約18萬平方米的大型高端商業綜合體,引進國際一線品牌,同時包含高端住宅、公寓、地標塔樓寫字樓、商業等多種業態。
公司表示,項目計劃會引進國際五星級品牌酒店、銀行總部、金融服務業、科技、信息通訊、傳媒、專業服務、生物醫藥健康、高端製造、金融科技等企業,構築當地的都市商業和商務核心平台。
計及此項目,華潤置地深圳大區東莞公司投資運營業務項目增至20個。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.